Gilder Gagnon Howe & CO LLC Moderna, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.07 Million - $5.01 Million	-13,606 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $2.8 Million - $6.12 Million	12,624 Added 1285.54%	13,606 $5.24 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $127,571 - $230,750	982 New	982 $231,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.